Open Access
Place of Duloxetine in Concervative Treatment Women and Men with Stress Urinary Incontinence
Author(s) -
V. I. Gorovyi,
В. Є. Литвинець,
Olena Gurzhenko
Publication year - 2021
Publication title -
zdorovʹe mužčiny
Language(s) - English
Resource type - Journals
eISSN - 2412-5547
pISSN - 2307-5090
DOI - 10.30841/2307-5090.1.2021.232524
Subject(s) - duloxetine , medicine , urinary incontinence , urology , duloxetine hydrochloride , stress incontinence , urethral sphincter , sphincter , gynecology , surgery , alternative medicine , pathology
History of introduction of duloxetine in medical practice, mechanism of action and using of duloxetine in concervative treatment women and men with stress urinary incontinence are shown. Modern structure of external urethral sphincter in women and men was shown with increasing of sphincter tone under duloxetine influence.
Duloxetine recommended by International Continent Society for initial treatment women with stress urinary incontinence but this drug gives only improvement of urine continence and quality of life with side effects. Duloxetine with connection with pelvic floor muscle training gives better results than using separately duloxetine and pelvic floor muscle training. Nausuea is the most frequency side symptom after using duloxetine. Results of own investigations were shown and indications for using duloxetine in women with stress urinary incontinence were summed up. The most positive results were obtained after combination of duloxetine with pelvic floor muscle training and electrostimulation of urethral sphincter. Duloxetine for treatment men with stress urinary incontinence after radical prostatectomy is only clinical tested. Estimation of efficacy of duloxetine in treatment men with stress urinary incontinence after open prostatectomy due to benign prostatic hyperplasia is needed.